Anton Gomez-Escolar – författare

• Examines the contemporary psychedelic phenomenon, including the history of criminalization and legalization, psychedelics’ effects on the brain, recent clinical research, and new therapeutic potentials• Explores substances like psilocybin, LSD, DMT, ayahuasca, ketamine, and MDMA, including scientific evidence for psychedelics’ potential to treat addiction, depression, anxiety, trauma, and neurodegenerative diseases• Includes extensive practical information on safety, risk, and harm reduction for both laypeople and mental health practitionersPresenting a comprehensive guide to the exciting new landscape around psychedelics, psychopharmacologist Anton Gomez-Escolar examines the long history of criminalizing and (slowly) legalizing these substances and their increasingly demonstrable positive effects on body, mind, and spirit.Exploring psilocybin, LSD, DMT, ayahuasca, ketamine, MDMA, and other substances, Gomez-Escolar looks at the multitude of scientific studies providing critical evidence for psychedelics’ ability to treat addiction, depression, anxiety, and trauma as well as their potential to treat neurodegenerative diseases such as Alzheimer’s. He provides key information for therapists and other health practitioners as well as explores the potential benefits and limitations of microdosing and how psychedelics could help with various neurological and mental health issues, including those related to the COVID-19 pandemic. Breaking down substances by type, the author looks at the main risks of each psychedelic and its benefits, best harm-reduction strategies, and the neural pathways each affects. Gomez-Escolar also includes a large selection of resources for people seeking to engage personally with psychedelics for healing.

En este libro aprenderá todos los fundamentos de los psicodélicos y por qué toda esta investigación es tan gran noticia para la salud pública en este siglo. Tras un viaje muy largo y extraño, puede que los psicodélicos vuelvan, por fin, para quedarse. Rick Doblin, PhD, Fundador y Director Ejecutivo, MAPS.En esta guía aprenderá todo lo esencial sobre la historia, neurociencia, legalidad, aplicaciones terapéuticas y reducción de riesgos de las sustancias psicodélicas más prometedoras para la ciencia. Tras décadas de prohibición internacional estas moléculas están volviendo a los laboratorios y las clínicas, de la mano de la ciencia más rigurosa, para revolucionar la forma en la que entendemos y tratamos la salud mental (depresión, ansiedad, traumas y adicciones). Descubra el mundo de la psilocibina, la MDMA, la DMT, la ketamina y la LSD, antes de que la sociedad se vea inmersa en esta revolución, que cambiará para siempre la percepción que tenemos de los psicodélicos. Esta guía será de interés tanto para terapeutas y otros profesionales de la salud mental interesados en las aplicaciones clínicas, como para padres y educadores que quieran entender el impacto social y la seguridad de los psicodélicos y otras sustancias, así como para cualquier adulto con curiosidad por conocer y explorar este nuevo mundo del renacimiento psicodélico.

Explores the benefits, risks, and growing acceptance of modern psychedelic therapy• Examines the contemporary psychedelic phenomenon, including the history of criminalization and legalization, psychedelics’ effects on the brain, recent clinical research, and new therapeutic potentials• Explores substances like psilocybin, LSD, DMT, ayahuasca, ketamine, and MDMA, including scientific evidence for psychedelics’ potential to treat addiction, depression, anxiety, trauma, and neurodegenerative diseases• Includes extensive practical information on safety, risk, and harm reduction for both laypeople and mental health practitionersPresenting a comprehensive guide to the exciting new landscape around psychedelics, psychopharmacologist Anton Gomez-Escolar examines the long history of criminalizing and (slowly) legalizing these substances and their increasingly demonstrable positive effects on body, mind, and spirit.Exploring psilocybin, LSD, DMT, ayahuasca, ketamine, MDMA, and other substances, Gomez-Escolar looks at the multitude of scientific studies providing critical evidence for psychedelics’ ability to treat addiction, depression, anxiety, and trauma as well as their potential to treat neurodegenerative diseases such as Alzheimer’s. He provides key information for therapists and other health practitioners as well as explores the potential benefits and limitations of microdosing and how psychedelics could help with various neurological and mental health issues, including those related to the COVID-19 pandemic. Breaking down substances by type, the author looks at the main risks of each psychedelic and its benefits, best harm-reduction strategies, and the neural pathways each affects. Gomez-Escolar also includes a large selection of resources for people seeking to engage personally with psychedelics for healing.